MedchemexpressGs-441524.Html

GS-441524

555299 25.0mg
EUR 90

Human IgG antibody Laboratories manufactures the www.medchemexpress.com/gs-441524.html reagents distributed by Genprice. The Www.Medchemexpress.Com/Gs-441524.Html reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact MedChemExpress Inc.. Other Www.Medchemexpress.Com/Gs-441524.Html products are available in stock. Specificity: Www.Medchemexpress.Com/Gs-441524.Html Category:

GS-441524

50mg
EUR 355

GS-441524

5mg
EUR 140

GS-441524

5x100mg
EUR 2925

GS-441524

10mg
EUR 2385

GS-441524

2mg
EUR 1185

GS-441524

5mg
EUR 1635

GS-441524

5x10mg
EUR 10400

Chemicals information

GS-441524

MBS5752425-25mg 25mg
EUR 200

GS-441524

MBS5752425-2mg 2mg
EUR 135

GS-441524

MBS5752425-50mg 50mg
EUR 250

GS-441524

MBS5752425-5mg 5mg
EUR 145

GS-441524

T7222-10mg 10mg Ask for price
Description: GS-441524

GS-441524

T7222-1g 1g Ask for price
Description: GS-441524

GS-441524

T7222-1mg 1mg Ask for price
Description: GS-441524

GS-441524

T7222-50mg 50mg Ask for price
Description: GS-441524

GS-441524

T7222-5mg 5mg Ask for price
Description: GS-441524

GS-441524 solution

555700 10.0mg
EUR 90

GS-441524 HCl

555735 5.0mg
EUR 150

GS 441524 triphosphate

MBS3610619-100mg 100mg
EUR 390

GS 441524 triphosphate

MBS3610619-10mg 10mg
EUR 220

GS 441524 triphosphate

MBS3610619-25mg 25mg
EUR 260

GS 441524 triphosphate

MBS3610619-50mg 50mg
EUR 320

GS 441524 triphosphate

MBS3610619-5mg 5mg
EUR 210

GS-441524 (Remdesivir Metabolite)

10-038 50 mg
EUR 501.36
Description: GS-441524 is the active prodrug of the broad-spectrum antiviral Remdesivir. GS-441524 is an adenosine nucleotide analog in viral RNA production. It is a nucleotide analog inhibitor of RNA-dependent RNA polymerases (RdRps). The compound interferes with the action of viral RNA polymerase and evades proofreading by viral exoribonuclease (ExoN), causing a decrease in viral RNA production (RNA synthesis arrest), either by terminating RNA chains or causing mutations. It inhibits MERS-CoV or SARS-CoV-infected HAE cultures (EC50=74nM and 69nM) and murine hepatitis virus (MHV) (EC50=30nM). In vivo, remdesivir (Prod. No. AG-CR1-3713) (25 and 50 mg/kg) reduces lung viral titers and prevents weight loss in a mouse model of SARS-CoV infection. Remdesivir (Prod. No. AG-CR1-3713) is used as a treatment for Ebola virus disease and Marburg virus infections and other single stranded RNA viruses such as respiratory syncytial virus, Junin virus, Lassa fever virus, Nipah virus, Hendra virus and the coronaviruses (including MERS and SARS viruses). Remdesivir is effective in the control of 2019-nCoV (COVID-19) infection in vitro. It now also has been studied as potential treatment of SARS-CoV-2 infections